| Typicality: | 0.325 |
| Saliency: | 0.177 |
| in conjunction with aeras | 3 | manner |
| vaccine → be developed by → gsk | 7 |
| vaccine → be made by → gsk | 4 |
| negative | neutral | positive |
| 0.058 | 0.801 | 0.142 |
| Raw frequency | 11 |
| Normalized frequency | 0.177 |
| Modifier score | 0.500 |
| Perplexity | 130.195 |